Yara International ASA Earnings Calls
| Release date | Jul 17, 2026 |
| EPS estimate | $1.12 |
| EPS actual | $1.01 |
| EPS Surprise | -9.82% |
| Revenue estimate | 5.139B |
| Revenue actual | 4.261B |
| Revenue Surprise | -17.08% |
| Release date | Apr 24, 2026 |
| EPS estimate | $0.760 |
| EPS actual | $0.82 |
| EPS Surprise | 7.89% |
| Revenue estimate | 3.995B |
| Revenue actual | 4.259B |
| Revenue Surprise | 6.61% |
| Release date | Feb 11, 2026 |
| EPS estimate | $0.550 |
| EPS actual | $0.580 |
| EPS Surprise | 5.45% |
| Revenue estimate | 3.907B |
| Revenue actual | 3.948B |
| Revenue Surprise | 1.05% |
| Release date | Oct 17, 2025 |
| EPS estimate | $0.688 |
| EPS actual | $0.670 |
| EPS Surprise | -2.62% |
| Revenue estimate | 4.17B |
| Revenue actual | 4.104B |
| Revenue Surprise | -1.58% |
Last 4 Quarters for Yara International ASA
Below you can see how YARIY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 17, 2025 |
| Price on release | $18.78 |
| EPS estimate | $0.688 |
| EPS actual | $0.670 |
| EPS surprise | -2.62% |
| Date | Price |
|---|---|
| Oct 13, 2025 | $18.62 |
| Oct 14, 2025 | $18.42 |
| Oct 15, 2025 | $18.87 |
| Oct 16, 2025 | $19.00 |
| Oct 17, 2025 | $18.78 |
| Oct 20, 2025 | $18.78 |
| Oct 21, 2025 | $18.50 |
| Oct 22, 2025 | $18.64 |
| Oct 23, 2025 | $18.83 |
| 4 days before | 0.88% |
| 4 days after | 0.218% |
| On release day | -0.0213% |
| Change in period | 1.10% |
| Release date | Feb 11, 2026 |
| Price on release | $24.08 |
| EPS estimate | $0.550 |
| EPS actual | $0.580 |
| EPS surprise | 5.45% |
| Date | Price |
|---|---|
| Feb 05, 2026 | $23.06 |
| Feb 06, 2026 | $23.62 |
| Feb 09, 2026 | $24.32 |
| Feb 10, 2026 | $24.50 |
| Feb 11, 2026 | $24.08 |
| Feb 12, 2026 | $23.95 |
| Feb 13, 2026 | $24.01 |
| Feb 17, 2026 | $23.34 |
| Feb 18, 2026 | $23.72 |
| 4 days before | 4.41% |
| 4 days after | -1.48% |
| On release day | -0.540% |
| Change in period | 2.87% |
| Release date | Apr 24, 2026 |
| Price on release | $28.96 |
| EPS estimate | $0.760 |
| EPS actual | $0.82 |
| EPS surprise | 7.89% |
| Date | Price |
|---|---|
| Apr 20, 2026 | $28.16 |
| Apr 21, 2026 | $28.15 |
| Apr 22, 2026 | $28.92 |
| Apr 23, 2026 | $28.92 |
| Apr 24, 2026 | $28.96 |
| Apr 27, 2026 | $28.90 |
| Apr 28, 2026 | $28.81 |
| Apr 29, 2026 | $28.55 |
| Apr 30, 2026 | $29.09 |
| 4 days before | 2.84% |
| 4 days after | 0.440% |
| On release day | -0.207% |
| Change in period | 3.29% |
| Release date | Jul 17, 2026 |
| Price on release | $23.42 |
| EPS estimate | $1.12 |
| EPS actual | $1.01 |
| EPS surprise | -9.82% |
| Date | Price |
|---|---|
| Jul 13, 2026 | $23.42 |
| Jul 14, 2026 | $24.15 |
| Jul 15, 2026 | $23.80 |
| Jul 16, 2026 | $23.43 |
| Jul 17, 2026 | $23.42 |
| Jul 20, 2026 | $23.14 |
| Jul 21, 2026 | $22.82 |
| Jul 22, 2026 | $23.19 |
| Jul 23, 2026 | $23.96 |
| 4 days before | 0% |
| 4 days after | 2.32% |
| On release day | -1.20% |
| Change in period | 2.32% |
Yara International ASA Earnings Call Transcript Summary of Q2 2026
Key points for investors: Yara delivered a strong Q2 with EBITDA (ex. special items) of $906 million, up 39% year‑on‑year, and the highest quarterly EBITDA since 2022 excluding that record year. Return on invested capital improved to 14.3% (partly supported by a $153 million gain from selling surplus EUA allowances). Crop nutrition deliveries were down 17% YoY due to demand deferral around peak price volatility and some production outages/turnarounds (Pilbara, Belle Plaine, Babrala). Demand has recently resurfaced and prices have rebounded in several regions, though market risk remains elevated given Middle East tensions. Yara announced the strategic acquisition of the Gulf Coast Ammonia (GCA) plant in Texas for $1.3 billion (1.3 Mtpa nameplate); management says this will materially strengthen its cost position, increase flexibility, and be accretive to cash flow and returns once closed. Operating cash flow was impacted by the seasonality/delayed buying, but free cash flow for the quarter was $583 million and net debt remained broadly stable after dividend payments. Management reiterated strict capital discipline, continued focus on the EBITDA/improvement program (US$560m of the 2027 target realized so far), and multiple pathways to profitable decarbonization (including CBAM advantages and CCS projects). Key near‑term risks: continued volatility in regional nitrogen prices, supply uncertainty tied to the Middle East, timing of GCA regulatory closing, and agricultural season/weather developments (El Niño uncertainty).
Sign In
Buy YARIY